The
global Xerostomia Therapeutics Market is expected to
reach USD 796.1 million by 2025, according to a new report by Grand View
Research, Inc. Increase in favorable reimbursement policies for xerostomia
products and growing awareness about associated diseases are the major factors
contributing toward market growth.
In
addition, increasing prevalence of xerostomia and associated diseases such as
Sjogren’s syndrome, diabetes, hypertension, and Parkinson’s disease has a
positive impact on the overall market. According to Colgate-Palmolive Company,
25 million people in the U.S. experience dry mouth. According to Sjogren
Syndrome Foundation of America, around 4 million Americans are suffering from
Sjogren’s syndrome, an autoimmune disorder.
Growing
initiatives for raising awareness about xerostomia and associated diseases are
expected to drive growth. For instance, Sjogren Syndrome Foundation of America
conducts awareness programs and supports patients suffering from the syndrome
in the U.S. and Canada. In 2012, the foundation launched the “5-Year
Breakthrough Goal” with an aim to reduce the time required to diagnose the
condition to less than 2.5 years by 2017.
Furthermore,
major players focus on acquiring emerging companies and conduct programs to
raise awareness about dry mouth condition. For instance, Orajel, a brand of
Church & Dwight Co., Inc. initiated a campaign with the help of iCrossing,
a digital marketing agency to educate parents about the importance of oral
care.
Browse
Details of Report @
http://www.grandviewresearch.com/industry-analysis/xerostomia-dry-mouth-therapeutics-market
http://www.grandviewresearch.com/industry-analysis/xerostomia-dry-mouth-therapeutics-market
Further key findings from the report suggest:
- The global
xerostomia (Dry Mouth) therapeutics market size was estimated at USD 602.3
million in 2016 and is expected to grow with CAGR of 3.2% from 2017 to
2025
- The OTC
segment dominated the market due to factors such as ease in availability,
affordability, and higher efficiency
- The dentifrices
segment dominated the market in terms of revenue in 2016. Higher adoption
of these products, accessibility, and affordability contribute to the
dominance of the segment.
- North
America held the largest share in 2016 owing to factors such as increasing
prevalence of diseases resulting in dry mouth and growing initiatives for
raising awareness about xerostomia
- The Asia
Pacific region is anticipated to witness lucrative growth over the next
decade due to increasing awareness of the disease and growing healthcare
expenditure
- Some of the
key players such as GlaxoSmithKline plc; Church & Dwight Co., Inc.;
and Colgate-Palmolive Company dominated the global xerostomia therapeutics
market in 2016
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment